Imkeldi (imatinib oral solution) — Medica
Acute lymphoblastic leukemia (Ph+ or ABL-class translocation)
Initial criteria
- Patient has Philadelphia chromosome-positive acute lymphoblastic leukemia OR patient has ABL-class translocation
Approval duration
1 year